高级检索
当前位置: 首页 > 详情页

miR-16 induction after CDK4 knockdown is mediated by c-Myc suppression and inhibits cell growth as well as sensitizes nasopharyngeal carcinoma cells to chemotherapy.

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Pathology, Third affiliated hospital, Guangzhou Medical University, Guangzhou 510150, China [2]Cancer Research Institute, Southern Medical University, Guangzhou 510515, China [3]Key Laboratory for Major Obstetric Diseases of Guangdong Province, Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China [4]Department of Pathology, Guangzhou Medical University, Guangzhou 510282, China [5]Cancer Center, Traditional Chinese Medicine-Integrated Hospital, Southern Medical University, Guangzhou, Guangdong 510315, China
出处:
ISSN:

关键词: NPC CDK4 miR-16 c-Myc Feedback loop

摘要:
Cyclin-dependent kinase 4 (CDK4) is a member of cyclin-dependent kinase family which regulates G1 to S cell cycle transition. CDK4 activity is increased in many tumor types. Here, we report a negative automodulatory feedback loop between CDK4 and miR-16 that regulates cell cycle progression in nasopharyngeal carcinoma (NPC). By miRNA array and real-time PCR, we identified upregulation of tumor suppressor miR-16a, which inhibited cell cycle progression and sensitized NPC cells to chemotherapy. CDK4 knockdown reduced the expression of c-Myc, the latter of which directly suppresses the miR-16 expression by directly binding to the miR-16 promoter. Moreover, we found that miR-16 upregulation could reduce CDK4 expression by repressing CCND1 and thus forms a feedback loop via the CDK4/c-Myc/miR-16/CCND1 pathway. Finally, miR-16 was negatively correlated with CDK4 expression in NPC biopsies. In summary, our results define a double-negative feedback loop involving CDK4 and miR-16 mediated by c-Myc that modulates NPC cell growth and chemotherapy sensitivity.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
最新[2025]版:
第一作者:
第一作者机构: [1]Department of Pathology, Third affiliated hospital, Guangzhou Medical University, Guangzhou 510150, China [3]Key Laboratory for Major Obstetric Diseases of Guangdong Province, Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China [4]Department of Pathology, Guangzhou Medical University, Guangzhou 510282, China
共同第一作者:
通讯作者:
通讯机构: [1]Department of Pathology, Third affiliated hospital, Guangzhou Medical University, Guangzhou 510150, China [2]Cancer Research Institute, Southern Medical University, Guangzhou 510515, China [3]Key Laboratory for Major Obstetric Diseases of Guangdong Province, Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China [4]Department of Pathology, Guangzhou Medical University, Guangzhou 510282, China [5]Cancer Center, Traditional Chinese Medicine-Integrated Hospital, Southern Medical University, Guangzhou, Guangdong 510315, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号